Akinsanya, K., AlQuraishi, M., Boija, A., Chodera, J., Cichońska, A., Ghassemi, M., … Elemento, O. (2025). Redefining druggable targets with artificial intelligence. Nat Biotechnol, 43(9), 1416–1418. https://doi.org/10.1038/s41587-025-02770-1

Akinsanya, Karen, Mohammed AlQuraishi, Ann Boija, John Chodera, Anna Cichońska, Marzyeh Ghassemi, Martha Head, et al. “Redefining druggable targets with artificial intelligence.” Nat Biotechnol 43, no. 9 (September 2025): 1416–18. https://doi.org/10.1038/s41587-025-02770-1.

Akinsanya K, AlQuraishi M, Boija A, Chodera J, Cichońska A, Ghassemi M, et al. Redefining druggable targets with artificial intelligence. Nat Biotechnol. 2025 Sep;43(9):1416–8.

Akinsanya, Karen, et al. “Redefining druggable targets with artificial intelligence.” Nat Biotechnol, vol. 43, no. 9, Sept. 2025, pp. 1416–18. Pubmed, doi:10.1038/s41587-025-02770-1.

Akinsanya K, AlQuraishi M, Boija A, Chodera J, Cichońska A, Ghassemi M, Head M, Jin W, Kibbe WA, Krogan N, LeVine MV, Moult J, Stuart L, Tourassi G, Zou J, Barzilay R, Elemento O. Redefining druggable targets with artificial intelligence. Nat Biotechnol. 2025 Sep;43(9):1416–1418.